Lacking Revenue, Jenscare Scientific Hopes IPO Investors Take Heart in Its Potential
The maker of devices to treat structural heart disease hopes to have its first product approved in the second half of next year as it prepares to list in Hong…
Cash-Strapped Cryofocus Medtech Scrambles to Raise Funds With IPO
With only 128 million yuan in cash left in its coffers, the maker of innovative medical devices is desperate to secure fresh capital with a second stab at a Hong…
Shanghai Pulse Medical Files for HK Listing Despite Weak Vital Stats
Company is the latest in a growing series of Chinese medical device makers to file for Hong Kong IPOs Key takeaways: Shanghai Pulse Medical has filed to list in Hong…
RELATED ARTICLES
-
Venus Medtech still seeking cure for governance problems
2500.HK - Increasing losses prompt Zephyrm Bioscience to seek funds through IPO
-
Junshi hopes new scientist CEO can cure its woes
1877.HK 688180.SHG
- B&K Corp eyes IPO to keep its slow-developing drugs alive
-
Kintor Pharma eyes regeneration with over-the-counter cosmetic treatments
9939.HK
-
Test results for new cancer drug take Akeso investors on wild ride
9926.HK
-
Facing revenue crisis, Ascletis Pharma tries to bulk up with obesity drugs
1672.HK
